Goldman Sachs analyst Noah Poponak lowered the firm’s price target on Booz Allen (BAH) to $80 from $93 and keeps a Sell rating on the shares. Revenue declined in the quarter at an accelerated pace, and the company revised FY26 guidance for revenue down 7%, EBITDA down 10%, and EPS down 13%, the analyst tells investors in a research note. A U.S. government funding re-prioritization is impacting Booz Allen, while Goldman also continues to see risk to margins as the customer looks to shift more risk to companies via contract terms.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BAH:
- BofA Double-Downgrades Booz Allen (BAH) after Weak Q2 Results
- Booz Allen Hamilton Earnings Call: Mixed Sentiment Amid Challenges
- Booz Allen price target lowered to $106 from $119 at Stifel
- Booz Allen price target lowered to $90 from $110 at Truist
- BofA double downgrades Booz Allen to Underperform on civil weakness
